Association between Circulating Ectodysplasin A and Diabetic Kidney Disease

Table 3

The significant correlations between EDA and clinical indices.

	All subjects ()		Control ()		All T2DM patients ()
	value	value	value	value	value	value
Age	0.365	0.048	-0.091	0.491	0.181	0.012
BMI	0.200	0.289	-0.126	0.342	0.136	0.062
WHR	-0.279	0.136	0.089	0.501	-0.005	0.945
Duration of T2DM	—	—	—	—	0.044	0.552
SBP	-0.050	0.795	-0.113	0.395	0.085	0.245
DBP	-0.233	0.216	-0.068	0.611	-0.046	0.533
FPG	-0.298	0.110	0.097	0.465	-0.110	0.133
2hPG	-0.292	0.117	0.014	0.916	-0.093	0.204
FIns	0.409	0.025	-0.073	0.585	0.255	0.000
2hCP	0.060	0.752	0.050	0.707	0.084	0.248
HbA1c	-0.296	0.112	-0.010	0.941	-0.043	0.561
HOMA-IR	0.202	0.285	-0.048	0.716	0.219	0.002
HOMA-β	0.420	0.021	-0.126	0.341	0.203	0.005
TG	-0.498	0.005	0.066	0.618	0.002	0.977
HDL-C	-0.284	0.128	-0.061	0.646	0.026	0.719
ALT	0.124	0.516	-0.249	0.057	0.091	0.212
BUN	-0.123	0.516	0.097	0.464	0.062	0.399
Creatinine	-0.107	0.575	0.103	0.439	0.182	0.012
eGFR	0.130	0.495	0.073	0.585	-0.150	0.040
Log(UACR)	0.277	0.000	-0.176	0.181	0.222	0.002